Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Philip Hampton.

Newcastle AuthorsTitleYearFull text
Dr Philip Hampton
Professor Nick Reynolds
Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab and Ustekinumab in Psoriasis: A Study from the British Association of Dermatologists Biologics and Immunomodulators Register2021
Dr Anna Dubois
Dr Simon Meggitt
Dr Philip Hampton
Description of a disease activity proforma for documentation of hidradenitis suppurativa severity and distribution, and suggestions for use as a patient-reported outcome measure2020
Dr Philip Hampton
New brodalumab psoriasis outcome data suggests that intermittent treatment is as effective as continuous dosing. Is it time to re-evaluate our treatment regimens?2020
Dr Hudaa Gopee
Dr Thomas Oliphant
Dr Philip Hampton
Toxic epidermal necrolysis occurring with immune checkpoint inhibitors2020
Dr Philip Hampton
Dan Richardson
Dr Kyle Montague
Professor Patrick Olivier
Usability testing of MySkinSelfie: a mobile phone application for skin self‐monitoring2020
Dr Philip Hampton
A standardization approach to compare treatment safety and effectiveness outcomes between clinical trials and real-world populations in psoriasis2019
Dr Philip Hampton
Comparison of drug discontinuation, effectiveness, and safety between clinical trial eligible and ineligible patients in BADBIR2018
Dr Philip Hampton
British Association of Dermatologists’ guidelines for the management of pemphigus vulgaris 20172017
Dr Philip Hampton
Despite numerous recent advances in dermatological therapy, the need for inpatient dermatology care remains considerable2017
Dr Philip Hampton
Treatment patterns and outcomes among adults admitted to hospital in the U.K. due to plaque or erythrodermic psoriasis2017
Dr Clifford Lawrence
Dr Catherine Blasdale
Dr Philip Hampton
Following up patients with cutaneous squamous cell carcinoma: 5-year data from a tertiary university centre2016
Dr Colin Muirhead
Professor Dorothy Newbury-Birch
Professor Eileen Kaner
Dr Eilish Gilvarry
Professor Vera Araujo-Soares
et al.
Examining the prevalence of Alcohol Use Disorders (AUD) in patients with skin disease, a cross-sectional study2015
Dr Philip Hampton
Professor Nick Reynolds
Predictors of response to increasing the dose of etanercept: results of an audit2013
Dr Philip Hampton
Dr Ralph Jans
Dr Ross Flockhart
Graeme Parker
Professor Nick Reynolds
et al.
Lithium regulates keratinocyte proliferation via glycogen synthase kinase 3 and NFAT2 (nuclear factor of activated T cells 2)2012